Palvella Therapeutics (PVLA) Shares Outstanding (Weighted Average) (2016 - 2024)
Historic Shares Outstanding (Weighted Average) for Palvella Therapeutics (PVLA) over the last 12 years, with Q3 2024 value amounting to $1.8 million.
- Palvella Therapeutics' Shares Outstanding (Weighted Average) rose 4321.74% to $1.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.8 million, marking a year-over-year increase of 4321.74%. This contributed to the annual value of $90.1 million for FY2023, which is 2142.59% up from last year.
- Palvella Therapeutics' Shares Outstanding (Weighted Average) amounted to $1.8 million in Q3 2024, which was up 4321.74% from $1.8 million recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Shares Outstanding (Weighted Average) registered a high of $90.1 million during Q4 2023, and its lowest value of $931000.0 during Q1 2023.
- Its 5-year average for Shares Outstanding (Weighted Average) is $45.4 million, with a median of $55.2 million in 2020.
- As far as peak fluctuations go, Palvella Therapeutics' Shares Outstanding (Weighted Average) crashed by 9873.7% in 2023, and later skyrocketed by 9013.61% in 2024.
- Quarter analysis of 5 years shows Palvella Therapeutics' Shares Outstanding (Weighted Average) stood at $54.5 million in 2020, then increased by 18.48% to $64.5 million in 2021, then grew by 14.91% to $74.2 million in 2022, then increased by 21.43% to $90.1 million in 2023, then crashed by 98.03% to $1.8 million in 2024.
- Its last three reported values are $1.8 million in Q3 2024, $1.8 million for Q2 2024, and $1.8 million during Q1 2024.